Initial investigation of combined single-photon emission computed tomography (SPECT) and magnetic resonance (MR) imaging of a human ovarian tumor xenograft using <sup>123</sup>I-bevacizumab

Randall, Leslie

308 - Poster Session A
Initial investigation of combined single-photon emission computed tomography (SPECT) and magnetic resonance (MR) imaging of a human ovarian tumor xenograft using ¹²³I-bevacizumab

Saturday, March 22, 2014: 6:05 PM

West Exhibit Hall (Tampa Convention Center)

L. M. Randall¹, M. J. Hamamura², D. H. Harris³, S. Ha⁴, W. Roeck⁴ and O. Nalcioglu⁴
¹University of California at Irvine Medical Center, Orange, CA, ²University of California Irvine, Irvine, CA, ³Sandoz Biopharmaceuticals, Unterach, Austria, ⁴Tu & Yuen Center for Functional Onco-Imaging, Irvine, CA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

308 - Poster Session A
Initial investigation of combined single-photon emission computed tomography (SPECT) and magnetic resonance (MR) imaging of a human ovarian tumor xenograft using ¹²³I-bevacizumab

308 - Poster Session A Initial investigation of combined single-photon emission computed tomography (SPECT) and magnetic resonance (MR) imaging of a human ovarian tumor xenograft using 123I-bevacizumab

308 - Poster Session A
Initial investigation of combined single-photon emission computed tomography (SPECT) and magnetic resonance (MR) imaging of a human ovarian tumor xenograft using ¹²³I-bevacizumab